Phocas Financial Corp’s Gilead Sciences GILD Stock Holding History

Phocas Financial Corp’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-6,862	Closed	-$543K	–	232
2016 Q3	$543K	Sell	6,862 -190	-3%	-$15.4K	0.04%	217
2016 Q2	$588K	Sell	7,052 -29,524	-81%	-$2.62M	0.04%	213
2016 Q1	$3.36M	Sell	36,576 -404	-1%	-$36.4K	0.26%	172
2015 Q4	$3.74M	Sell	36,980 -5,663	-13%	-$589K	0.29%	162
2015 Q3	$4.19M	Sell	42,643 -195	-0.5%	-$21.7K	0.35%	139
2015 Q2	$5.01M	Sell	42,838 -641	-1%	-$70K	0.41%	116
2015 Q1	$4.27M	Sell	43,479 -1,490	-3%	-$151K	0.34%	139
2014 Q4	$4.24M	Sell	44,969 -1,322	-3%	-$137K	0.37%	125
2014 Q3	$4.93M	Buy	46,291 +468	+1%	+$45.8K	0.44%	107
2014 Q2	$3.8M	Buy	+45,823	New	+$3.57M	0.33%	133

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Phocas Financial Corp's GILD Position: Q4 2016 in Review

Phocas Financial Corp sold out of Gilead Sciences (GILD) in Q4 2016, closing a stake of 6,862 shares — an estimated $543K sold.

Phocas Financial Corp first reported a position in GILD in Q2 2014 and held it in 10 quarters. The position peaked at $5.01M in Q2 2015. 1,572 funds tracked by Wall St. Rank hold GILD as of Q4 2016.

Phocas Financial Corp reported no remaining Gilead Sciences position as of Q4 2016 after selling out during the quarter.
Phocas Financial Corp sold 6,862 Gilead Sciences shares in Q4 2016, an estimated $543K.
Phocas Financial Corp first reported a position in Gilead Sciences in Q2 2014 and held it in 10 quarters.
Phocas Financial Corp's Gilead Sciences position peaked at $5.01M in Q2 2015.
1,572 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2016.

Based on Phocas Financial Corp's 13F filing for Q4 2016, filed 13 Feb 2017.